 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || Convalescent Plasma for COVID-19 / Del Rosario University
Clinical, Journal: Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study. (Pubmed Central) - Jun 29, 2022
P2/3
However, CP is safe and could be a therapeutic option to reduce the hospital length of stay. Trial registration NCT04332835.
- || Convalescent Plasma for COVID-19 / Del Rosario University, Convalescent Plasma / Ahvaz Jundishapur University of Medical Sciences, Convalescent Plasma / Royal College of Surgeons in Ireland
Clinical, Retrospective data, Review, Journal: Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials. (Pubmed Central) - Nov 24, 2021
These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care.
- | Convalescent Plasma for COVID-19 / Del Rosario University
Journal: Comment on: Nature and Dimensions of the Systemic Hyper-Inflammation and its Attenuation by Convalescent Plasma in Severe COVID-19. (Pubmed Central) - Jun 3, 2021
Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care. No abstract available
- | Convalescent Plasma for COVID-19 / Del Rosario University
Trial completion: CP-COVID-19: Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study (clinicaltrials.gov) - Nov 27, 2020
P2/3, N=92, Completed, Sponsor: Universidad del Rosario
No abstract available Recruiting --> Completed
- | Convalescent Plasma for COVID-19 / Del Rosario University
Enrollment open, Trial initiation date: CP-COVID-19: Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study (clinicaltrials.gov) - Aug 17, 2020
P2/3, N=90, Recruiting, Sponsor: Universidad del Rosario
Recruiting --> Completed Not yet recruiting --> Recruiting | Initiation date: May 2020 --> Aug 2020
- | Convalescent Plasma for COVID-19 / Del Rosario University
Trial completion, Trial completion date: CP-COVID-19: Convalescent Plasma for Patients With COVID-19: A Pilot Study (clinicaltrials.gov) - Aug 17, 2020
P2, N=10, Completed, Sponsor: Universidad del Rosario
Not yet recruiting --> Recruiting | Initiation date: May 2020 --> Aug 2020 Not yet recruiting --> Completed | Trial completion date: Dec 2020 --> Jul 2020
- | Convalescent Plasma for COVID-19 / Del Rosario University
New P2/3 trial: CP-COVID-19: Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study (clinicaltrials.gov) - Apr 3, 2020
P2/3, N=80, Not yet recruiting, Sponsor: Universidad del Rosario
- | Convalescent Plasma for COVID-19 / Del Rosario University
New P2 trial: CP-COVID-19: Convalescent Plasma for Patients With COVID-19: A Pilot Study (clinicaltrials.gov) - Apr 2, 2020
P2, N=10, Not yet recruiting, Sponsor: Universidad del Rosario